Screener
Fulgent Genetics, Inc. FLGT Therapeutic Development — General And Administrative Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Three Months Ended March 31, 2026 | Laboratory Services | Therapeutic Development | Total |
|---|---|---|---|
| Revenue | $71,051 | $87 | $71,138 |
| Less: | |||
| Adjusted cost of revenue | 48,179 | 8 | 48,187 |
| Adjusted research and development | 6,461 | 4,178 | 10,639 |
| Adjusted selling and marketing | 11,576 | — | 11,576 |
| Adjusted general and administrative | 20,052 | 357 | 20,409 |
| Total adjusted operating loss | $(15,217) | $(4,456) | $(19,673) |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s therapeutic development — general and administrative expense?
- Fulgent Genetics, Inc. (FLGT) reported therapeutic development — general and administrative expense of $357K in Q1 2026.
- How has Fulgent Genetics, Inc.'s therapeutic development — general and administrative expense changed year-over-year?
- Fulgent Genetics, Inc.'s therapeutic development — general and administrative expense increased by 36.8% year-over-year, from $261K to $357K.
- What is the long-term trend for Fulgent Genetics, Inc.'s therapeutic development — general and administrative expense?
- Over 3 years (2022 to 2025), Fulgent Genetics, Inc.'s therapeutic development — general and administrative expense has grown at a 161.2% compound annual growth rate (CAGR), from $70K to $1.25M.
- What does therapeutic development — general and administrative expense mean?
- This represents the overhead and administrative costs allocated to the therapeutic development segment, such as management salaries, legal fees, and office expenses. It is used to evaluate the operational efficiency and cost management of the segment's support functions.
Ask your AI about Fulgent Genetics, Inc.'s therapeutic development — general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude